H.R. 5357 · 116th Congress
Innovation Network and Capital Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PetersSponsorNo cosponsors.
This bill establishes and provides funds through FY2025 for a grant program in the National Institutes of Health (NIH) to expand the commercialization of biomedical products.
What it does: CRS summary · Introduced in House · Dec 6, 2019
Innovation Network and Capital Act of 2019
This bill establishes and provides funds through FY2025 for a grant program in the National Institutes of Health (NIH) to expand the commercialization of biomedical products. NIH shall award grants or contracts to entities that have received funding from either the Small Business Innovation Research Program or the Small Business Technology Transfer Program of NIH. Awardees must use the funds to support participation in specified NIH programs and activities related to the commercialization stage of research, later stage research and development, technology transfer, and commercialization technical assistance.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Innovation Network and Capital Act of 2019
Latest action (Dec 9, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Dec 6, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.